In the absence of hard evidence, US medical associations and the National Institutes of Health have not recommended remdesivir for treatment of Covid-19 so far
from Latest News https://ift.tt/2Y4YEtq
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Gilead's Covid-19 cure trial may yield results ahead of schedule: Report
Saturday, April 25, 2020
Related Posts:
Govt makes FPI's job easier, introduces single form for foreign investorsCommon application form for FPIs has been devised with a view to enhan… Read More
Commercial mining will end coal shortage: Former CIL chief P BhattacharyaAnything short of faster opening up of the coal sector to commercial m… Read More
Switch to EMV chip debit cards by December 31: SBI tells customersEMV chip card protects against counterfeit (skimming) card fraud. EMV … Read More
PSU banks plans closure of 70 overseas offices during this fiscalPSBs closed down 35 foreign operations last year from Latest News htt… Read More
0 comments: